HealthEquity (HQY) Competitors

CDK Global (NASDAQ:CDK) and HealthEquity (NASDAQ:HQY) are both mid-cap computer and technology companies, but which is the better stock? We will compare the two businesses based on the strength of their profitability, community ranking, earnings, dividends, media sentiment, risk, valuation, institutional ownership and analyst recommendations.

Does the media prefer CDK or HQY?

In the previous week, HealthEquity had 4 more articles in the media than CDK Global. MarketBeat recorded 8 mentions for HealthEquity and 4 mentions for CDK Global. CDK Global's average media sentiment score of 1.10 beat HealthEquity's score of 0.08 indicating that HealthEquity is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
CDK Global	1 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
HealthEquity	4 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Do analysts prefer CDK or HQY?

HealthEquity has a consensus target price of $96.17, indicating a potential upside of 21.55%. Given CDK Global's higher probable upside, analysts plainly believe HealthEquity is more favorable than CDK Global.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
CDK Global	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	N/A
HealthEquity	0 Sell rating(s)	0 Hold rating(s)	11 Buy rating(s)	0 Strong Buy rating(s)	3.00

Which has higher earnings and valuation, CDK or HQY?

CDK Global has higher revenue and earnings than HealthEquity. CDK Global is trading at a lower price-to-earnings ratio than HealthEquity, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
CDK Global	$1.67B	3.82	$1.03B	$2.09	26.20
HealthEquity	$999.59M	6.89	$55.71M	$0.64	123.63

Does the MarketBeat Community favor CDK or HQY?

HealthEquity received 148 more outperform votes than CDK Global when rated by MarketBeat users. Likewise, 69.24% of users gave HealthEquity an outperform vote while only 56.11% of users gave CDK Global an outperform vote.

Company	Underperform	Outperform
CDK Global	Outperform Votes 363 56.11%	Underperform Votes 284 43.89%
HealthEquity	Outperform Votes 511 69.24%	Underperform Votes 227 30.76%

Which has more volatility and risk, CDK or HQY?

CDK Global has a beta of 0.95, meaning that its stock price is 5% less volatile than the S&P 500. Comparatively, HealthEquity has a beta of 0.55, meaning that its stock price is 45% less volatile than the S&P 500.

Do insiders and institutionals hold more shares of CDK or HQY?

92.9% of CDK Global shares are held by institutional investors. Comparatively, 99.6% of HealthEquity shares are held by institutional investors. 0.5% of CDK Global shares are held by insiders. Comparatively, 2.2% of HealthEquity shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Is CDK or HQY more profitable?

CDK Global has a net margin of 14.28% compared to CDK Global's net margin of 5.57%. HealthEquity's return on equity of 67.84% beat CDK Global's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
CDK Global	14.28%	67.84%	11.15%
HealthEquity	5.57%	6.91%	4.41%

Summary

HealthEquity beats CDK Global on 10 of the 17 factors compared between the two stocks.